Skip to main content
BTB Korea Co.,Ltd logo

BTB Korea Co.,Ltd — Investor Relations & Filings

Ticker · 219750 ISIN · KR7219750007 KO Wholesale and retail trade
Open in API
Filings indexed 502 across all filing types
Latest filing 2024-05-29 Legal Proceedings Report
Country KR South Korea
Listing KO 219750

About BTB Korea Co.,Ltd

http://www.btbkorea.com/

BTB Korea Co., Ltd. is a healthcare equipment company that manufactures and sells medical and cosmetic devices. The company operates through Medical Device and Bio business divisions. Its product range includes ultrasound systems, positron emission tomography (PET) scanners, and in-vitro diagnostic equipment. In addition to its medical offerings, the company provides cosmetic equipment and supplies high-quality life science products to a diverse market that includes hospitals, laboratories, and research institutes. BTB Korea focuses on integrating medical systems and cell research to provide comprehensive beauty and health solutions.

Recent filings

Filing Released Lang Actions
기타시장안내 (개선계획서 제출)
Legal Proceedings Report Classification · 100% confidence The document is a short regulatory notice from the Korea Exchange regarding the submission of an improvement plan by GTG Wellness following a listing eligibility review. It describes the regulatory process for potential delisting or trading resumption. Since it is a regulatory announcement regarding market status and does not fit into specific categories like financial reports or M&A, it falls under the general regulatory filing category.
2024-05-29 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the period 2024-01-01 to 2024-03-31, submitted by '주식회사 한국비티비' (formerly GTG Wellness). It contains detailed corporate information, management discussion, capital changes, and governance details, which are characteristic of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean
주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the suspension of stock trading for (주)지티지웰니스 due to a listing eligibility review. It is a formal announcement from a regulatory body or exchange regarding trading status, which does not fit into specific categories like earnings, dividends, or M&A. Therefore, it falls under the general regulatory filing category.
2024-05-07 Korean
기타시장안내 (상장적격성 실질심사 대상 결정)
Delisting Announcement Classification · 100% confidence The document is a formal announcement from the Korea Exchange (KRX) regarding the company 'GTG Wellness' being placed under review for potential delisting (상장적격성 실질심사 대상 결정). This is a regulatory notice concerning the company's listing status on the KOSDAQ market. Since it does not fit into specific categories like 'Delisting Announcement' (which usually refers to the final act of removal) or 'Legal Proceedings', and it is a formal regulatory notification, it falls under the 'RNS' (Regulatory Filings) category.
2024-05-07 Korean
회생절차종결신청
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory filing submitted by GTG Wellness regarding an application to terminate rehabilitation proceedings (회생절차 종결신청). It details the legal status of the company's rehabilitation, debt repayment, and M&A activities. Since this is a specific regulatory announcement regarding legal proceedings and corporate restructuring that does not fit into categories like M&A (which usually refers to the deal itself) or financial reports, it is best classified as a general regulatory filing.
2024-05-03 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a corporate merger (회사합병 결정) between GTG Wellness and Dongin Biotech. It details the merger schedule, valuation methods, financial impact, and regulatory compliance. This document is a formal regulatory filing required by the Korea Exchange (KRX) for significant corporate events, specifically M&A activity. While it contains merger details, it is a formal regulatory disclosure rather than a standalone M&A press release or a general report, fitting the 'TAR' (M&A Activity) category as it is the primary document announcing and detailing the merger terms.
2024-04-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.